There is hope with Spravato
Spravato EsKetamine
What is Spravato ?
If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression(TRD).
It might be time to talk to your doctor about a different treatment approach. See what makes SPRAVATO® different and learn more about other patients’ experiences with SPRAVATO®.
Our Partnership with SPRAVATO
SPRAVATO™ nasal spray is a different kind of medication taken with an oral antidepressant for adults with treatment-resistant depression – a first in decades approved by the FDA.
If you’ve struggled with depression and tried two or more antidepressants* in your current episode without adequate relief, talk to your provider at Allen Psychiatry to see if you have treatment-resistant depression. This treatment is covered by most insurance.
This treatment is for those with depression who have failed at least two antidepressants. Patients will be required to have someone drive them home and will need to stay in our office for two hours. The initial treatment consists of twice weekly treatments for four weeks and then treatment once weekly. Ongoing treatment is usually required.
Learn more about SPRAVATO at https://www.spravato.com/
A brighter future is possible.
Safe, effective, and FDA-approved, Esketamine is an incredibly effective option for individuals 18 and over who suffer from treatment-resistant depression. If you’re feeling a lack of hope with failed treatment attempts, are tired of the side effects of drugs, and just want something that provides sustained relief without stifling your spirit—know that positive, powerful change is absolutely possible with Esketamine.
“By the end of the EsKetamine treatment, things were better than I could have imagined.
— Sarah H.
You are not alone.
Depression affects millions of Americans and is the second leading cause of disability.
16 million
affected each year
6.7%
of all adults in the U.S.
More than 26k
deaths from suicide
4 million
patients who can’t take antidepressants
Safe, Effective, and FDA-Approved:
Esketamine Treatment Offers an Array of Benefits
✓ FDA-cleared
✓ Non-invasive
✓ Not ECT
✓ Long-lasting relief
✓ Widely covered by insurance
✓ Proven to work
Who is Esketamine For?
Esketamine treatment is best suited for individuals 18 and over who suffer from treatment-resistant depression.
We can’t wait to bring you sustained hope and happiness.
If you think you’re a right fit for EsKetamine treatment, start here.
“Since EsKetamine, my perspective on life has been so positive that I know there is hope.”
— Martha F.